Zhong Chao Han
Président chez Tianjin Amcellgene Engineering Co., Ltd.
Profil
Zhong Chao Han is currently the Chairman & Chief Scientist of Tianjin Amcellgene Engineering Co., Ltd.
and the Chairman of Beijing Health & Biotech Co., Ltd.
Postes actifs de Zhong Chao Han
| Sociétés | Poste | Début |
|---|---|---|
Tianjin Amcellgene Engineering Co., Ltd.
 Tianjin Amcellgene Engineering Co., Ltd. BiotechnologyHealth Technology Tianjin Amcellgene Engineering Co., Ltd. engages in the research and development of cell therapeutic products. It offers human adipose-derived, human umbilical cord, and human amniotic membrane-derived mesenchymal stem cells. The company was founded in August 2004 and is headquartered in Tianjin, China. | Président | - |
Beijing Health & Biotech Co., Ltd.
 Beijing Health & Biotech Co., Ltd. BiotechnologyHealth Technology Beijing Health & Biotech Co., Ltd. engages in the development of stem cell technologies. Its business offers diabetes therapy, cardiovascular diseases therapy, neurological diseases therapy, autoimmune diseases therapy, limb ischemic disease therapy, sub-health and anti-aging therapy, and stem cell banking. The company was founded on January 8, 2007 and is headquartered in Beijing, China. | Président | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Tianjin Amcellgene Engineering Co., Ltd.
Tianjin Amcellgene Engineering Co., Ltd. BiotechnologyHealth Technology Tianjin Amcellgene Engineering Co., Ltd. engages in the research and development of cell therapeutic products. It offers human adipose-derived, human umbilical cord, and human amniotic membrane-derived mesenchymal stem cells. The company was founded in August 2004 and is headquartered in Tianjin, China. | Health Technology |
Beijing Health & Biotech Co., Ltd.
Beijing Health & Biotech Co., Ltd. BiotechnologyHealth Technology Beijing Health & Biotech Co., Ltd. engages in the development of stem cell technologies. Its business offers diabetes therapy, cardiovascular diseases therapy, neurological diseases therapy, autoimmune diseases therapy, limb ischemic disease therapy, sub-health and anti-aging therapy, and stem cell banking. The company was founded on January 8, 2007 and is headquartered in Beijing, China. | Health Technology |
